Approved indications: Topical calcitriol ointment is approved for the treatment of mild to moderate plaque psoriasis on the skin in adults and pediatric patients 2 years of age and older, and is not intended for very severe or highly extensive psoriasis.

Off‑label uses: Clinicians may choose calcitriol for psoriasis in sensitive areas such as skin folds or the genital region, or as part of combination regimens with topical corticosteroids or phototherapy; these patterns of use are supported mainly by smaller studies and clinical experience rather than large comparative trials.

Efficacy expectations: Many patients notice some reduction in redness, scaling, and thickness within about 2–4 weeks, with greater clearing over 8–12 weeks; clinical trials show that a substantial proportion of patients achieve clear or almost clear skin with twice‑daily use, while many others have partial but meaningful improvement.

Comparison to similar drugs: Compared with other vitamin D–based topical treatments, calcitriol offers similar overall effectiveness for mild to moderate plaque psoriasis and is often better tolerated on delicate or intertriginous skin, so it is frequently chosen for these sites and used alongside moisturizers or topical steroids to optimize control.

Typical dosing: For adults and children 2 years and older with mild to moderate plaque psoriasis, a thin layer of calcitriol ointment (3 mcg/g) is usually applied to affected areas twice daily, morning and evening; in children 2–6 years, the total weekly amount is typically limited to about 100 grams, and in patients 7 years and older to about 200 grams.

How to apply: Use the ointment only on psoriasis plaques, not on the face, lips, eyes, genital or rectal areas, or broken or infected skin; gently rub a thin film into clean, dry skin, wash hands after application unless treating the hands, avoid airtight or occlusive dressings unless specifically instructed, and let the ointment absorb before applying other skin products to the same area.

Special dosing instructions: Do not apply more often than prescribed or to a larger body surface than recommended, since this may increase the risk of side effects, including high blood calcium; if you are using other topical psoriasis medicines or undergoing phototherapy, follow your clinician’s specific schedule for when to apply calcitriol relative to those treatments.

Missed dose and overdose: If you miss a dose, apply it as soon as you remember unless it is almost time for your next scheduled application, in which case skip the missed dose and resume your regular regimen without doubling; if you have used too much ointment or applied it over very large areas and develop symptoms such as nausea, constipation, extreme thirst, frequent urination, or confusion, stop using it and contact a healthcare provider, poison control center, or emergency services right away.

Common side effects: The most common effects are mild burning, stinging, itching, dryness, or redness at the application site, and occasionally a temporary flare or irritation of psoriasis; these usually occur early in therapy, are mild to moderate, and often improve as the skin adjusts.

Serious or rare adverse effects: Overuse on large body areas or for long periods can rarely raise blood calcium levels, which may cause nausea, vomiting, poor appetite, constipation, increased thirst or urination, muscle weakness, confusion, or unusual tiredness; severe skin irritation, blistering, or swelling of treated areas should also prompt immediate medical evaluation and stopping the ointment until assessed.

Warnings and precautions: Use with caution if you have kidney disease, a history of high or low blood calcium, parathyroid or other calcium‑metabolism disorders, or if you take high‑dose vitamin D, calcium supplements, or thiazide diuretics; safety is not established in children under 2 years; in pregnancy and breastfeeding, use only if clearly needed, on the smallest area for the shortest time, and avoid applying where an infant’s mouth could contact the skin.

Safety compared with other therapies: Unlike many topical corticosteroids, calcitriol does not thin the skin and has very low systemic absorption when used as directed, so it is generally considered safe for long‑term, intermittent use on limited areas, particularly on sensitive skin sites.

Reporting side effects and safety updates: In the United States, side effects can be reported to the FDA MedWatch program online or by calling 1‑800‑FDA‑1088, and current safety communications can be found on FDA and manufacturer websites.

Drug and supplement interactions: Because calcitriol can influence calcium balance, use it carefully if you take oral vitamin D products, multivitamins with high vitamin D content, calcium supplements, or thiazide diuretics, and always inform your clinician about all prescription and over‑the‑counter medicines and herbal products you use.

Other treatments and procedures: Let your provider know if you are receiving ultraviolet (UV) light treatments or phototherapy, or using other topical psoriasis medications on the same skin areas, so the regimen can be adjusted to avoid excessive irritation or altered calcium metabolism; foods and moderate alcohol do not have specific interactions with topical calcitriol, though heavy alcohol intake may worsen psoriasis in general.

Precautions and monitoring: People with kidney impairment, a history of hypercalcemia, or disorders of calcium or parathyroid function may need extra caution and, if large areas are treated for long periods, occasional blood tests to check calcium and kidney function; consult your healthcare professional before starting calcitriol if any of these conditions apply.

Sun and UV exposure: Treated skin can be more sensitive to sunlight, so avoid intentional tanning and minimize intense sun or artificial UV exposure on treated areas, use protective clothing, and follow your clinician’s guidance if calcitriol is combined with phototherapy or photodynamic treatments.

Q: What is topical calcitriol used for?
A: It is a prescription ointment used to treat mild to moderate plaque psoriasis on the skin in adults and children 2 years of age and older.

Q: How long does it take for calcitriol ointment to start working?
A: Many people notice some improvement in redness, scaling, and thickness within about 2–4 weeks, with further clearing often seen over 8–12 weeks of regular twice‑daily use.

Q: Is calcitriol ointment a steroid, and can it thin my skin?
A: Calcitriol is not a steroid; it is a form of vitamin D, and when used as directed it does not cause skin thinning the way long‑term use of strong topical steroids can.

Q: Can I use calcitriol on my face, groin, or other sensitive areas?
A: The product labeling advises against use on the face, lips, eyes, or genital and rectal areas, but clinicians sometimes choose it for certain sensitive sites under close supervision, so follow the specific instructions given by your prescriber.

Q: Do I need to avoid sunlight while using this ointment?
A: You do not have to stay indoors, but treated areas may be more sensitive to sun, so you should limit intense sun or tanning beds on those areas and use protective clothing as advised by your clinician.

Q: Can I use moisturizers or other psoriasis creams with calcitriol?
A: Moisturizers are often used along with calcitriol, usually applied at different times of day, and other psoriasis creams such as topical steroids may also be combined under a clinician’s guidance, so ask your provider how to time each product.

Storage: Store calcitriol ointment at room temperature (68–77°F / 20–25°C), with brief excursions between 59–86°F (15–30°C); keep the tube tightly closed, protect from excessive heat, moisture, and direct light, do not freeze or refrigerate, and keep out of the reach of children and pets.

Disposal: Do not flush unused ointment down the toilet or pour it into sinks; when no longer needed or expired, discard it in the household trash in a sealed container or use a community or pharmacy drug take‑back program, following local regulations.